GLOBUS MEDICAL INC GMED

Rank #1757 · NYSE · $10.6B market cap

Audited by DELOITTE & TOUCHE LLP, no going-concern flag in the latest filing.

Score

42.8

P/E

86.2

P/B

5.74

ROE

6.7%

Op. Margin

8.5%

Debt Ratio

58%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Weak

P/E 86.2x, P/B 5.74x. Ranks in the top 64% of the universe.

Profitability ★★☆☆☆

Average

ROE 6.7%. Ranks in the top 52% of the universe.

Safety ★★★★☆

Good

Debt ratio 58%. Ranks in the top 26% of the universe.

Growth ★★★★★

Excellent

Revenue growth of 53.3% year over year. Ranks in the top 7% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2012	–	$0.1B	$0.1B	$0.2B	–	28
2013	–	$0.1B	$0.1B	$0.2B	–	27
2014	–	$0.1B	$0.1B	$0.3B	–	33
2015	–	$0.1B	$0.1B	$0.4B	–	31
2016	–	$0.1B	$0.1B	$0.5B	–	25
2017	–	$0.2B	$0.1B	$0.6B	–	16
2018	$0.6B	$0.2B	$0.1B	$0.7B	27.3	15
2019	$0.6B	$0.2B	$0.1B	$0.8B	25.4	14
2020	$0.7B	$0.2B	$0.2B	$1.0B	23.7	13
2021	$0.8B	$0.2B	$0.2B	$1.2B	21.9	15
2022	$0.8B	$0.1B	$0.1B	$1.4B	14.1	15
2023	$1.0B	$0.2B	$0.1B	$1.5B	17.9	15
2024	$1.0B	$0.2B	$0.2B	$1.7B	22.3	62
2025	$1.6B	$0.1B	$0.1B	$1.8B	8.5	58